INCLINE VILLAGE, Nev., June 1, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that Peter Garcia, the company's vice president and chief financial officer, will present at the Jefferies 2017 Healthcare Conference next week in New York. The presentation will be webcast live and will occur on Friday, June 9, 2017 at 8:30 a.m. EDT. John McLaughlin, PDL's president and chief executive officer, will not attend the conference given that the company's Annual Meeting of Stockholders is scheduled for the same day in Incline Village, NV.
To access the live and subsequently archived webcast of the presentation, go to the company's website at http://www.pdl.com and go to "Presentations and Events." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.
About PDL BioPharma
PDL seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. In late 2012, PDL began providing alternative sources of capital through royalty monetizations and debt facilities and in 2016, began making equity investments in commercial stage companies, the first being Noden Pharma DAC. PDL has committed over $1.4 billion and funded approximately $1.1 billion in these investments to date. PDL is headquartered in Incline Village, Nevada.
For more information, please visit www.pdl.com. PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pdl-biopharma-to-present-at-the-jefferies-2017-healthcare-conference-300466817.html
SOURCE PDL BioPharma, Inc.